根据一份提交给美国证券交易委员会(SEC)的文件,美国医疗保险和医疗补助服务中心(CMS)已更新了针对非侵入性骨生长刺激器的医保付费标准。此项更新将于2026年5月18日正式生效。Bioventus Inc. 作为相关领域的参与者,此医保政策调整可能对其业务运营及市场环境产生潜在影响。
根据一份提交给美国证券交易委员会(SEC)的文件,美国医疗保险和医疗补助服务中心(CMS)已更新了针对非侵入性骨生长刺激器的医保付费标准。此项更新将于2026年5月18日正式生效。Bioventus Inc. 作为相关领域的参与者,此医保政策调整可能对其业务运营及市场环境产生潜在影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.